高齢者を対象としたフォルシガ錠の特定臨床経験調査

基本情報

NCT ID

NCT02200627

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

1,724

治験依頼者名

AstraZeneca

概要

The purpose of the investigation is to confirm the following under the post-marketing actual use of Forxiga Tablets (hereinafter referred to as Forxiga) in elderly patients. * Development of ADRs specified as Key Investigation Items and the risk factors * Contributing factors possibly having an impact on the safety and efficacy * Development of ADRs unexpected from the Precautions for use and ADRs under actual drug use

対象疾患

依頼者（Sponsor）